|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.20 HKD | -7.27% |
|
+3.48% | -33.56% |
| 07-16 | Chinese drugmakers with big ambitions struggle to recruit staff for global expansion | RE |
| 06-25 | CanSino Biologics Gets Registration Certificate for Meningitis Vaccine in Argentina | MT |
| Market Cap | 8.33B 9.64B 1.23B 1.07B 991M 914M 1.72B 118B 1.76B 11.85B 4.66B 57.97B 4.62B 4.51B 200B | P/E 2026 * |
33.8x | P/E 2027 * | 12.5x |
|---|---|---|---|---|---|
| Enterprise Value | 8.25B 9.54B 1.22B 1.06B 981M 904M 1.7B 117B 1.74B 11.73B 4.61B 57.38B 4.57B 4.47B 198B | EV / Sales 2026 * |
5.78x | EV / Sales 2027 * | 4.32x |
| Free-Float |
39.28% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.27% | ||
| 1 week | +3.48% | ||
| Current month | +4.13% | ||
| 1 month | +3.39% | ||
| 3 months | -34.09% | ||
| 6 months | -37.93% | ||
| Current year | -33.56% |
| 1 week | 22.72 |  | 25.4 |
| 1 month | 19.22 | | 25.4 |
| Current year | 19.22 | | 41.64 |
| 1 year | 19.22 | | 56.55 |
| 3 years | 14.8 | | 56.55 |
| 5 years | 14.8 | | 398 |
| 10 years | 14.8 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hui Hua Mao
PRN | Corporate Officer/Principal | 64 | 13/01/2009 |
Tao Zhu
CTO | Chief Tech/Sci/R&D Officer | 53 | 13/01/2009 |
Xue Feng Yu
CEO | Chief Executive Officer | 62 | 13/01/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Shou Bai Chao
BRD | Director/Board Member | 63 | 22/06/2018 |
Xue Feng Yu
CHM | Chairman | 62 | 13/01/2009 |
Zhong Qi Shao
BRD | Director/Board Member | 63 | 28/05/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/26/25 A | Sell | Director | 4,600 | 0.0069% | ||
| 9/26/24 A | Other | Chief Executive Officer | 20,000 | 0.0151% | ||
| 9/9/24 A | Other | Founder | 30,000 | 0.0226% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.27% | +3.48% | -38.95% | -13.11% | 1.32B | |
| -0.78% | +1.49% | +22.62% | -6.54% | 69.07B | |
| +0.67% | +0.93% | +37.53% | +198.53% | 51.77B | |
| +0.94% | +39.60% | +39.60% | +39.60% | 43.63B | |
| +1.12% | -1.76% | -50.16% | -52.75% | 40.89B | |
| -2.30% | +2.80% | +59.08% | -26.47% | 30.84B | |
| -1.48% | -8.33% | +94.36% | -48.95% | 25.06B | |
| +0.53% | +0.61% | +70.32% | +92.24% | 23.3B | |
| -5.57% | +3.01% | +3.19% | +174.11% | 20.92B | |
| -0.86% | -1.99% | +68.42% | +124.39% | 16.71B | |
| Average | -1.54% | -0.24% | +30.60% | +48.11% | 32.35B | |
| Weighted average by Cap. | -0.53% | -1.30% | +31.42% | +47.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.43B 1.65B 211M 184M 170M 157M 295M 20.28B 302M 2.03B 799M 9.93B 791M 774M 34.2B | 1.79B 2.07B 265M 231M 213M 197M 371M 25.49B 379M 2.55B 1B 12.48B 994M 972M 42.97B |
| Net income | 144M 167M 21.3M 18.62M 17.18M 15.83M 29.84M 2.05B 30.51M 205M 80.76M 1B 80M 78.24M 3.46B | 395M 457M 58.28M 50.93M 47M 43.32M 81.65M 5.61B 83.46M 562M 221M 2.75B 219M 214M 9.46B |
| Net Debt | -85.1M -98.43M -12.56M -10.97M -10.12M -9.33M -17.59M -1.21B -17.98M -121M -47.6M -592M -47.15M -46.12M -2.04B | -581M -672M -85.66M -74.86M -69.08M -63.67M -120M -8.25B -123M -826M -325M -4.04B -322M -315M -13.91B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | HK$23.20 | -7.27% | 898,040 |
| 16/07/26 | HK$25.02 | +2.12% | 598,800 |
| 15/07/26 | HK$24.50 | +4.26% | 1,062,399 |
| 14/07/26 | HK$23.50 | +0.43% | 470,200 |
| 13/07/26 | HK$23.40 | -0.09% | 740,687 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6185 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
